Science has made remarkable advances in prenatal screening, but false positives and false negative results can occur, and there are ethical concerns.
New drug to treat hypoactive sexual desire in women, Vyleesi, is not very effective and has several drawbacks. It is NOT Viagra for women.
uBiome claims that its SmartJane test's proprietary technology empowers customers to assess their own vaginal health. The company is being investigated for fraudulent billing practices, and the rationale for the test makes no sense.
This ND recommends peat therapy, including peat baths, peat tampons, and peat bras, for a variety of conditions including infertility and HPV infections. The evidence is lacking.
Practicing after he lost his license, chiropractor Nicholas LeRoy used escharotics to treat a woman's cervical dysplasia. As result, she lost her uterus. Ex-naturopath Britt Hermes was taught to use escharotic treatments at Bastyr; she has since realized that they are "unproven, dangerous, and very stupid."
Chiropractor Disregards the Loss of His License, Continues to Treat Patients with Cervical Dysplasia with Escharotics
A chiropractor who bills himself as a chiropractic gynecologist has continued to practice after his license was permanently revoked. Among his many questionable practices, Nick LeRoy is treating cervical dysplasia with escharotics, a potentially dangerous replacement for conventional treatments to prevent cancer.
"Mary is really bitchy today; she must be on the rag." Comments like this are all too common, and are misguided. In her new book, Robyn Stein DeLuca dispels the myths about how hormones affect women's moods and mental health, myths that have contributed to unequal treatment of women. Junk science supported the myths; good science debunks them.
In its new report, the ACOG remains clear on the lack of solid evidence in support of claimed benefits of water immersion during the first stage of labor. Inexplicably, though, it has inappropriately softened its stance on restricting underwater delivery to proper clinical trials.